VivoSim Labs, Inc.
VIVS · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.00 | -0.00 | 0.00 |
| FCF Yield | -376.34% | -1,121.10% | -1,025.25% | -710.37% |
| EV / EBITDA | 3.55 | 0.01 | 0.70 | 2.23 |
| Quality | ||||
| ROIC | -110.43% | -302.06% | -103.50% | -35.44% |
| Gross Margin | 96.53% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 3.80 | 1.00 | 0.72 | 0.74 |
| Growth | ||||
| Revenue 3-Year CAGR | -26.99% | -58.27% | – | -11.93% |
| Free Cash Flow Growth | 35.53% | -14.77% | -44.48% | 35.45% |
| Safety | ||||
| Net Debt / EBITDA | 4.69 | 0.10 | 0.77 | 2.34 |
| Interest Coverage | -1,261.60 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -119,935.96 | 110.50 | 149.95 | 0.00 |